Effect of digoxin fab antibody on the measurement of total and free digitoxin by fluorescence polarization and a new chemiluminescent immunoassay

Therapeutic Drug Monitoring

Volumn 21, Issue 2, 1999, Pages 251-255

  Dasgupta, Amitava ^a   Wells, Alice ^a   Datta, Pradip ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b Chiron Diagnostics   (United States)

Author keywords

Chemiluminescent; Digibind; Digitoxin; Fluorescence polarization

Indexed keywords

DIGITOXIGENIN; DIGOXIN; DIGOXIN ANTIBODY F(AB) FRAGMENT;

ARTICLE; CHEMOLUMINESCENCE; DRUG COMPETITION; DRUG DETERMINATION; DRUG OVERDOSE; FLUORESCENCE POLARIZATION; IMMUNOASSAY; PRIORITY JOURNAL;

CARDIOTONIC AGENTS; CHEMILUMINESCENT MEASUREMENTS; DIGITOXIN; DIGOXIN; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS;

EID: 0032897307     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199904000-00018     Document Type: Article

References (16)

1. Soldin SJ. Digoxin - issues and controversies. Clin Chem 1986; 32:5-12
2. Koren G, Soldin SJ. Cardiac glycosides. Clin Lab Med 1987;7: 587-606.
3. Stone JA. Soldin SJ. An update on digoxin. Clin Chem 1989;35: 1326-31.
4. Larsen A, Storstein L. Digitoxin kinetics and renal excretion in children. Clin Pharmacol Ther 1973;19:387-95.
5. Storstein L. Digitoxin metabolism on a maintenance regimen and after a single dose. Clin Pharmacol Ther 1977;21:125-40.
6. Antman EM, Wenger TL, Butler VP, Haber E, Smith TW. Treatment of 150 cases of life threatening digitalis intoxication with digoxin specific antibody fragment. Circulation 1990;81:1744-52.
7. Rainey PM. Effects of digoxin immune fab (ovine) on digoxin iimmunoassays. Am J Clin Pathol 1989;92:779-86.
8. Ujhelyi M. Cummings DM, Green P, Ellison M, Vlasses P. Effect of digoxin fab antibodies on five digoxin immunoassays. Ther Drug Monit 1990;12:288-92.
9. Crossey MJ, Dasgupta A. Effects of digoxin like immunoreactive substances and digoxin fab antibodies on the new digoxin microparticle immunoassay. Ther Drug Monit 1997;19:185-90.
10. Lemon M, Andrews DJ, Binks AM, Georgiou GA. Concentrations of free serum digoxin after treatment with antibody fragment. Br Med J 1987;295:1520-1.
11. Hursting MJ, Raisys VA, Opheim KE, Bell JL, Trobaugh GB, Smith TW. Determination of free digoxin concentrations in serum for monitoring fab treatment of digoxin overdose. Clin Chem 1987; 33:1652-5.
12. Erdmann E, Mair W, Knedel M, Schaumann W. Digitalis intoxication and treatment with digoxin antibody fragments in renal failure. Klin Wochenschr 1989;67:16-9.
13. Wood WG, Farber P, Kurowski V. A case of divergent digitoxin values under treatment of a patient with acute digitoxin overdose with digitalis antibody fragment. Klin Wochenschr 1990;68:324-7.
14. Jortani SA, Trepanier D, Yatscoff RW, Valdes R. Convergence of three methods to resolve discrepant immunoassay digitoxin results. Clin Chem 1997;43:1805-1808.
15. Clifton CD, McIntyre WJ, Zannikos PN, Harrison MR, Chandler MH. Free and total serum digoxin concentrations in a renal failure patient after treatment with digoxin immune fab. Clin Pharm 1988; 8:441-445.
16. Ujhelyi MR, Curry RW, Robinson JD. Management of unusually high serum digoxin concentrations. Drug Intell Clin Pharm 1988; 22:345-346.